AVM

Arch Venture Management Portfolio holdings

AUM $299M
1-Year Est. Return 19.47%
This Quarter Est. Return
1 Year Est. Return
-19.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
-$24M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
10
New
Increased
Reduced
Closed

Top Buys

1
+$45.4M

Top Sells

1
+$2.46M
2
+$52.4K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.53B
$88.7M 43%
4,540,132
MAZE
2
Maze Therapeutics
MAZE
$1.58B
$45.4M 22%
+4,120,053
RAPP
3
Rapport Therapeutics
RAPP
$1.33B
$37.5M 18.21%
3,728,738
ERAS icon
4
Erasca
ERAS
$686M
$15.1M 7.34%
11,055,554
VERV
5
DELISTED
Verve Therapeutics
VERV
$9.12M 4.42%
2,008,809
GOSS icon
6
Gossamer Bio
GOSS
$561M
$8.78M 4.26%
8,055,916
UBX
7
DELISTED
Unity Biotechnology
UBX
$1.05M 0.51%
1,004,817
QTTB icon
8
Q32 Bio
QTTB
$34.3M
$532K 0.26%
320,482
CERO
9
DELISTED
CERo Therapeutics
CERO
$16.1K 0.01%
1,105
-3,592
OMIC
10
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
– –
-126,630